1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Sukits, S.F.
Lin, L.-L.
Malakian, K.
Powers, R.
Xu, G.-Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
310
895
906
10.1006/jmbi.2001.4790
11453696
Solution structure of the tumor necrosis factor receptor-1 death domain.
2001
10.2210/pdb1ich/pdb
pdb_00001ich
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
12807.777
TUMOR NECROSIS FACTOR RECEPTOR-1
DEATH DOMAIN
R347K
1
man
polymer
TNF-1
no
no
MAHKPQSLDTDDPATLYAVVENVPPLRWKEFVKRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGR
VLRDMDLLGCLEDIEEALCGPAALPPAPSLLR
MAHKPQSLDTDDPATLYAVVENVPPLRWKEFVKRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGR
VLRDMDLLGCLEDIEEALCGPAALPPAPSLLR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
BL-21 (DE) PLYS
PLASMID
PRSET(T7)
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-04-01
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2001-04-01
REL
REL
The structure was determinined using 3D triple-resonance experiments with the enhanced-sensitivity pulse field gradient approach.
1
3D_15N-separated_NOESY
3D_13C-separated_NOESY
4D_13C-separated_NOESY
10 mM
4.0
ambient
308
K
The structures were based on a total of 1167 distance constraints from NOE and H-Bond, 117 dihedral angle constraints from 3D HNHA and TALOS program and 81 pairs of CA/CB chemical shift contraints.
Distance geometry, Simulated annealing molecular dynamics
1 mM sample
10 mM Sodium acetate at pH 4.0, 10 mM DTT
Badger, J., Kumar, R.A., Yip, P.
structure solution
X-PLOR
9.8
Delaglio, F.
processing
NMRPipe
1.8, 2000
Garrett, D.
data analysis
PIPP
4.2.2, 1998
Badger, J., Kumar, R.A., Yip, P.
refinement
X-PLOR
9.8
600
Varian
UNITYPLUS
n
1
315
A
n
2
316
A
n
3
317
A
n
4
318
A
n
5
319
A
n
6
320
A
n
7
321
A
n
8
322
A
n
9
323
A
n
10
324
A
n
11
325
A
n
12
326
A
PRO
327
n
13
PRO
327
A
ALA
328
n
14
ALA
328
A
THR
329
n
15
THR
329
A
LEU
330
n
16
LEU
330
A
TYR
331
n
17
TYR
331
A
ALA
332
n
18
ALA
332
A
VAL
333
n
19
VAL
333
A
VAL
334
n
20
VAL
334
A
GLU
335
n
21
GLU
335
A
ASN
336
n
22
ASN
336
A
VAL
337
n
23
VAL
337
A
PRO
338
n
24
PRO
338
A
PRO
339
n
25
PRO
339
A
LEU
340
n
26
LEU
340
A
ARG
341
n
27
ARG
341
A
TRP
342
n
28
TRP
342
A
LYS
343
n
29
LYS
343
A
GLU
344
n
30
GLU
344
A
PHE
345
n
31
PHE
345
A
VAL
346
n
32
VAL
346
A
LYS
347
n
33
LYS
347
A
ARG
348
n
34
ARG
348
A
LEU
349
n
35
LEU
349
A
GLY
350
n
36
GLY
350
A
LEU
351
n
37
LEU
351
A
SER
352
n
38
SER
352
A
ASP
353
n
39
ASP
353
A
HIS
354
n
40
HIS
354
A
GLU
355
n
41
GLU
355
A
ILE
356
n
42
ILE
356
A
ASP
357
n
43
ASP
357
A
ARG
358
n
44
ARG
358
A
LEU
359
n
45
LEU
359
A
GLU
360
n
46
GLU
360
A
LEU
361
n
47
LEU
361
A
GLN
362
n
48
GLN
362
A
ASN
363
n
49
ASN
363
A
GLY
364
n
50
GLY
364
A
ARG
365
n
51
ARG
365
A
CYS
366
n
52
CYS
366
A
LEU
367
n
53
LEU
367
A
ARG
368
n
54
ARG
368
A
GLU
369
n
55
GLU
369
A
ALA
370
n
56
ALA
370
A
GLN
371
n
57
GLN
371
A
TYR
372
n
58
TYR
372
A
SER
373
n
59
SER
373
A
MET
374
n
60
MET
374
A
LEU
375
n
61
LEU
375
A
ALA
376
n
62
ALA
376
A
THR
377
n
63
THR
377
A
TRP
378
n
64
TRP
378
A
ARG
379
n
65
ARG
379
A
ARG
380
n
66
ARG
380
A
ARG
381
n
67
ARG
381
A
THR
382
n
68
THR
382
A
PRO
383
n
69
PRO
383
A
ARG
384
n
70
ARG
384
A
ARG
385
n
71
ARG
385
A
GLU
386
n
72
GLU
386
A
ALA
387
n
73
ALA
387
A
THR
388
n
74
THR
388
A
LEU
389
n
75
LEU
389
A
GLU
390
n
76
GLU
390
A
LEU
391
n
77
LEU
391
A
LEU
392
n
78
LEU
392
A
GLY
393
n
79
GLY
393
A
ARG
394
n
80
ARG
394
A
VAL
395
n
81
VAL
395
A
LEU
396
n
82
LEU
396
A
ARG
397
n
83
ARG
397
A
ASP
398
n
84
ASP
398
A
MET
399
n
85
MET
399
A
ASP
400
n
86
ASP
400
A
LEU
401
n
87
LEU
401
A
LEU
402
n
88
LEU
402
A
GLY
403
n
89
GLY
403
A
CYS
404
n
90
CYS
404
A
LEU
405
n
91
LEU
405
A
GLU
406
n
92
GLU
406
A
ASP
407
n
93
ASP
407
A
ILE
408
n
94
ILE
408
A
GLU
409
n
95
GLU
409
A
GLU
410
n
96
GLU
410
A
ALA
411
n
97
ALA
411
A
LEU
412
n
98
LEU
412
A
CYS
413
n
99
CYS
413
A
n
100
414
A
n
101
415
A
n
102
416
A
n
103
417
A
n
104
418
A
n
105
419
A
n
106
420
A
n
107
421
A
n
108
422
A
n
109
423
A
n
110
424
A
n
111
425
A
n
112
426
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
MET
315
A
MET
1
1
Y
1
A
ALA
316
A
ALA
2
1
Y
1
A
HIS
317
A
HIS
3
1
Y
1
A
LYS
318
A
LYS
4
1
Y
1
A
PRO
319
A
PRO
5
1
Y
1
A
GLN
320
A
GLN
6
1
Y
1
A
SER
321
A
SER
7
1
Y
1
A
LEU
322
A
LEU
8
1
Y
1
A
ASP
323
A
ASP
9
1
Y
1
A
THR
324
A
THR
10
1
Y
1
A
ASP
325
A
ASP
11
1
Y
1
A
ASP
326
A
ASP
12
1
Y
1
A
GLY
414
A
GLY
100
1
Y
1
A
PRO
415
A
PRO
101
1
Y
1
A
ALA
416
A
ALA
102
1
Y
1
A
ALA
417
A
ALA
103
1
Y
1
A
LEU
418
A
LEU
104
1
Y
1
A
PRO
419
A
PRO
105
1
Y
1
A
PRO
420
A
PRO
106
1
Y
1
A
ALA
421
A
ALA
107
1
Y
1
A
PRO
422
A
PRO
108
1
Y
1
A
SER
423
A
SER
109
1
Y
1
A
LEU
424
A
LEU
110
1
Y
1
A
LEU
425
A
LEU
111
1
Y
1
A
ARG
426
A
ARG
112
1
Y
1
A
A
O
H
LEU
LEU
396
401
1.54
1
A
A
O
H
LEU
GLU
405
409
1.56
1
A
A
O
H
LEU
GLY
389
393
1.58
1
A
ARG
341
0.259
SIDE CHAIN
1
A
ARG
348
0.316
SIDE CHAIN
1
A
ARG
358
0.223
SIDE CHAIN
1
A
ARG
365
0.270
SIDE CHAIN
1
A
ARG
368
0.247
SIDE CHAIN
1
A
ARG
379
0.176
SIDE CHAIN
1
A
ARG
380
0.246
SIDE CHAIN
1
A
ARG
381
0.215
SIDE CHAIN
1
A
ARG
384
0.215
SIDE CHAIN
1
A
ARG
385
0.274
SIDE CHAIN
1
A
ARG
394
0.277
SIDE CHAIN
1
A
ARG
397
0.297
SIDE CHAIN
1
A
ASN
363
179.96
90.89
1
A
ALA
387
71.77
34.22
SOLUTION STRUCTURE OF THE TUMOR NECROSIS FACTOR RECEPTOR-1 DEATH DOMAIN
1
N
N
A
PRO
327
A
PRO
13
HELX_P
A
VAL
337
A
VAL
23
1
1
11
A
ARG
341
A
ARG
27
HELX_P
A
GLY
350
A
GLY
36
1
2
10
A
SER
352
A
SER
38
HELX_P
A
ASN
363
A
ASN
49
1
3
12
A
CYS
366
A
CYS
52
HELX_P
A
THR
382
A
THR
68
1
4
17
A
ALA
387
A
ALA
73
HELX_P
A
MET
399
A
MET
85
1
5
13
A
LEU
401
A
LEU
87
HELX_P
A
CYS
413
A
CYS
99
1
6
13
APOPTOSIS
death domain, APOPTOSIS
TNR1A_HUMAN
UNP
1
345
P19438
AHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRV
LRDMDLLGCLEDIEEALCGPAALPPAPSLLR
345
455
1ICH
316
426
P19438
A
1
2
112
1
initiating methionine
MET
315
1ICH
A
P19438
UNP
1
1
ARG
engineered mutation
LYS
347
1ICH
A
P19438
UNP
376
33